IRIS
SCICALI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.428
EU - Europa 3.673
AS - Asia 2.502
SA - Sud America 476
AF - Africa 387
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 11.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.306
SG - Singapore 1.250
RU - Federazione Russa 1.240
IT - Italia 1.061
NL - Olanda 706
CN - Cina 678
BR - Brasile 405
CI - Costa d'Avorio 240
IE - Irlanda 238
VN - Vietnam 158
KR - Corea 130
IN - India 123
CA - Canada 85
GB - Regno Unito 81
SN - Senegal 77
DE - Germania 65
SE - Svezia 55
UA - Ucraina 54
FI - Finlandia 41
PL - Polonia 40
MX - Messico 28
AR - Argentina 27
TR - Turchia 27
FR - Francia 22
JP - Giappone 22
BJ - Benin 20
HK - Hong Kong 20
ES - Italia 17
ZA - Sudafrica 16
BD - Bangladesh 14
NG - Nigeria 13
AT - Austria 11
CL - Cile 11
IR - Iran 11
LT - Lituania 11
UZ - Uzbekistan 11
CO - Colombia 9
IQ - Iraq 9
MA - Marocco 9
PK - Pakistan 8
EC - Ecuador 7
ID - Indonesia 6
VE - Venezuela 6
CH - Svizzera 5
PY - Paraguay 5
BG - Bulgaria 4
IL - Israele 4
KE - Kenya 4
AL - Albania 3
BE - Belgio 3
GR - Grecia 3
LB - Libano 3
NP - Nepal 3
PE - Perù 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GD - Grenada 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SA - Arabia Saudita 2
SV - El Salvador 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MN - Mongolia 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.468
Salva come PNG Salva come JPEG
Città #
Dallas 934
Singapore 799
Santa Clara 715
Eygelshoven 676
Moscow 567
Chandler 434
Chicago 282
Hefei 260
Ashburn 251
Abidjan 240
Dublin 235
Catania 208
Civitanova Marche 152
Seoul 130
San Jose 124
Boardman 123
Los Angeles 120
Beijing 118
Rome 88
Kochi 81
Dakar 77
Cambridge 66
New York 64
Lawrence 60
Andover 58
Jacksonville 56
Dong Ket 51
Ho Chi Minh City 42
Wilmington 42
Milan 41
São Paulo 37
Warsaw 36
Des Moines 34
Buffalo 30
Montreal 30
Toronto 30
Orem 29
Nanjing 28
Palermo 27
Hanoi 25
Bremen 24
Denver 23
Lappeenranta 23
Stockholm 22
Tokyo 22
Houston 21
The Dalles 21
Cotonou 20
Carrara 19
Chennai 19
Padova 19
Brooklyn 18
Hong Kong 18
Belo Horizonte 17
Rosolini 16
Seattle 16
Amsterdam 15
London 15
Messina 15
Poplar 15
Johannesburg 14
Munich 14
Saint Petersburg 14
Atlanta 13
Columbus 13
Manchester 13
San Francisco 13
Abuja 12
Ankara 12
Menlo Park 12
Boston 11
Council Bluffs 11
Mexico City 11
Rio de Janeiro 11
Shenyang 11
Turku 11
Bari 10
Brasília 10
Enna 10
Gravina di Catania 10
Hebei 10
San Mateo 9
Tehran 9
Washington 9
Istanbul 8
Naples 8
Ottawa 8
Querétaro 8
Reggio Emilia 8
Helsinki 7
Mumbai 7
Phoenix 7
Pollenza 7
Città Sant'Angelo 6
Curitiba 6
Guangzhou 6
Leawood 6
Mascalucia 6
Nuremberg 6
Salvador 6
Totale 8.161
Salva come PNG Salva come JPEG
Nome #
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 509
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 502
Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study 340
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 238
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 169
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 159
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 157
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 154
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 148
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 148
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 140
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 140
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 138
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 137
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 134
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 131
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 130
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 127
Clinical and molecular biomarkers for diagnosis and staging of nafld 127
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 126
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 126
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 125
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 122
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 121
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 120
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? 119
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 119
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 119
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 119
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 118
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 118
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 117
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 117
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 114
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 112
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 112
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 110
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 108
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 106
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 104
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 103
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 102
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 102
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 101
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 100
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 98
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 98
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 98
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 97
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 96
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency 96
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 95
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 94
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 94
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 94
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 93
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 90
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 89
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 89
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 88
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 88
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice 87
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 87
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 86
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 86
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients 86
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study 86
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 84
Triglycerides to high density lipoprotein cholesterol ratio (TG/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes 83
Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease 82
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 82
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 81
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk 81
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 81
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 80
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 79
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience 78
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 78
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 78
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 77
Advancements in risk stratification and management strategies in primary cardiovascular prevention 77
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 77
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 76
Corticosteroid replacement therapy in hepatoadrenal syndrome: case report with a review of the literature. 76
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients with Stable Cirrhosis. 76
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 75
Impatto del profilo lipidico sulla malattia aterosclerotica in due differenti coorti di pazienti ad alto rischio cardiovascolare 74
Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction—An Updated Review of the Literature 74
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia 73
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 73
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group 71
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 71
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 70
Associations between Host Genetic Variants and Subgingival Microbiota in Patients with the Metabolic Syndrome 69
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 69
L'emoglobina glicosilata, meglio della curva da carico, permette l'identificazione di soggetti con prediabete ed elevato rischio cardiovascolare 68
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 67
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies 66
Studio dell'effetto incretinivo e della funzione beta cellulare in soggetti con prediabete e diabete di neo diagnosi 65
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 65
Totale 11.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021166 0 0 0 0 0 0 19 3 14 37 31 62
2021/2022534 37 57 1 21 90 38 70 41 27 7 21 124
2022/20231.115 69 95 33 137 105 170 5 192 214 14 42 39
2023/2024798 37 118 50 27 45 165 52 89 10 27 104 74
2024/20252.943 70 400 138 261 554 390 134 77 145 226 337 211
2025/20265.743 384 447 1.126 523 967 2.137 159 0 0 0 0 0
Totale 11.693